Valeant Canada LP v. Generic Partners Canada Inc. re: GLUMETZA®

Representing Valeant in proceedings brought under the Patented Medicines (Notice of Compliance) Regulations relating to GLUMETZA®, a medication used to treat type 2 diabetes.